毒素的剂量在宫静脉炎:超声波指导改变了注射实践吗?
Alexandre Kreisler1, Léa Mortain2, Kaëlig Watel1
1Department of Neurology and Movement Disorders, CHU Lille, F-59037 Lille, France.
Toxins
|October 25, 2024
概括
在宫 dystonia 中注射肉毒素的超声波指导针对更多的肌肉,包括深层肌肉. 与非指导注射相比,这种方法导致更稳定的长期剂量.
科学领域:
- 神经学 神经学
- 医疗技术 医疗技术 医学技术
背景情况:
- 宫性 dystonia 通常用肉毒素注射来治疗.
- 注射技术,包括指导方法,可以影响治疗结果.
- 指导方法包括触摸,超声波 (美国) 和电肌图.
研究的目的:
- 为了研究从非指导注射过渡到用于宫 dystonia 的 US-指导注射后,目标肌肉和肉毒素剂量的修改.
- 确定与美国指导注射相关的长期剂量趋势.
主要方法:
- 研究了一组82名患有宫性 dystonia 的患者.
- 患者最初接受非指导注射,后来转向美国指导注射.
- 分析了注射周期,持续时间,目标肌肉和剂量的数据.
主要成果:
- 与非指导方法相比,美国指导注射涉及更多的肌肉,特别是深层肌肉.
- 虽然根据美国指导,总肉毒素剂量和肌肉数量较高,但平均每肌肉剂量较低.
- 长期分析显示,在美国指导期间,总剂量稳定,每肌肉平均剂量下降.
结论:
- 指导方法显著影响瘤毒素注射策略的宫 dystonia,影响目标肌肉和剂量.
- 美国的指导似乎促进了更稳定的治疗结果,可能是由于注射精度提高.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
656
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
656
Skeletal Muscle Relaxants: Therapeutic Uses
468
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
468
Depolarizing Blockers: Pharmocokinetics
311
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
311
Skeletal Muscle Relaxants: Adverse Effects
338
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
338
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
395
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
395
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K


